Atlas Trials

Candidiasis, Invasive

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Candidiasis, Invasive

RecordFirmDate
Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2) (NCT03997929)Central Hospital, Nancy, France2020-01-20
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) (NCT03363841)Scynexis, Inc.2017-11-15
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis (NCT02244606)Scynexis, Inc.2014-09-01
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) (NCT01945281)Merck Sharp & Dohme LLC2014-01-15
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) (NCT01165320)Merck Sharp & Dohme LLC2010-07-06
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections (NCT00413218)Astellas Pharma Inc2007-03-08

Track Candidiasis, Invasive automatically

Every clearance here is in the API, with alerts when new ones post.